More than half of patients affected by cancer experience pain of moderate-to-severe
intensity, often in multiple sites, and of different etiologies and underlying mechanisms. The …

Background Cancer stage at diagnosis is an important prognostic indicator for patient
outcomes, with detection at later stages associated with increased mortality and morbidity …

Background Early diagnosis interventions such as symptom awareness campaigns
increasingly form part of global cancer control strategies. However, these strategies will …

PURPOSE: The aim of this study was to determine how frequently pruritus ani (PA) is a
symptom secondary to benign or malignant colon and anorectal pathology. METHODS: One …

Anal carcinoma is a relatively rare tumor that accounts for approximately 2% of
gastrointestinal malignancies and less than 7% of anorectal cancers. Most anal tumors …

Background Gay, bisexual and other men who have sex with men (GBM) living with HIV
have a substantially elevated risk of anal cancer (85 cases per 100,000 person-years vs 1–2 …

Anal cancer is uncommon neoplasm with an incidence of 2 new cases per 100,000 per year
in the USA, accounting approximately 0.4% of all tumors and 2.5% of gastrointestinal …

PURPOSE Radiochemotherapy is the standard treatment for anal carcinoma (ACa). Intensity-
modulated radiotherapy (IMRT) has been introduced, allowing focused irradiation of the …

Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in
detection, staging and assessment post treatment, in anal cancer - PMC Back to Top Skip to …

Background: We aim to ascertain prognostic factors in the current management of anal
cancer within this study. Methods: We reviewed the management and outcomes of anal …